What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Chemotherapy
Helmut Gadner spends much of his time researching Surgery, Internal medicine, Chemotherapy, Gastroenterology and Acute lymphocytic leukemia.
The various areas that Helmut Gadner examines in his Surgery study include Sarcoma and Langerhans cell histiocytosis.
His Internal medicine research includes themes of Immunology and Oncology.
His Chemotherapy study combines topics in areas such as Stage and Radiation therapy.
His research integrates issues of Hemophagocytic lymphohistiocytosis, Chemotherapy regimen and Antimetabolite in his study of Gastroenterology.
His Acute lymphocytic leukemia research is multidisciplinary, incorporating perspectives in Hematopoietic stem cell transplantation, Childhood Acute Lymphoblastic Leukemia, Gene rearrangement and Cohort study.
His most cited work include:
- Contemporary classification of histiocytic disorders (689 citations)
- Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90 (581 citations)
- Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. (577 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Surgery, Immunology, Chemotherapy and Pathology.
His Internal medicine research integrates issues from Gastroenterology and Oncology.
His Surgery research incorporates themes from Clinical trial and Pediatrics.
His Immunology study which covers Molecular biology that intersects with Gene.
His Chemotherapy research is multidisciplinary, relying on both Methotrexate, Radiation therapy, Toxicity and Prednisone.
His Acute lymphocytic leukemia study combines topics from a wide range of disciplines, such as Childhood Acute Lymphoblastic Leukemia, El Niño, Gene rearrangement and Minimal residual disease.
He most often published in these fields:
- Internal medicine (37.75%)
- Surgery (23.76%)
- Immunology (22.28%)
What were the highlights of his more recent work (between 2006-2017)?
- Internal medicine (37.75%)
- Surgery (23.76%)
- Immunology (22.28%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Surgery, Immunology, Langerhans cell histiocytosis and Pediatrics.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology.
His primary area of study in Surgery is in the field of Radiation therapy.
His Immunology study integrates concerns from other disciplines, such as Cytotoxic T cell, Stem cell and Transplantation.
His Pediatrics study incorporates themes from Leukemia, Lymphoblastic Leukemia, Epidemiology and Prospective cohort study.
His research investigates the connection between Acute lymphocytic leukemia and topics such as Childhood Acute Lymphoblastic Leukemia that intersect with problems in Gene rearrangement and Maintenance therapy.
Between 2006 and 2017, his most popular works were:
- Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95 (416 citations)
- Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000 (359 citations)
- Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. (321 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of study are Internal medicine, Surgery, Pediatrics, Langerhans cell histiocytosis and Immunology.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology.
His study in Chemotherapy and Etoposide is carried out as part of his studies in Surgery.
His work focuses on many connections between Chemotherapy and other disciplines, such as Methotrexate, that overlap with his field of interest in Maintenance therapy.
The Langerhans cell histiocytosis study combines topics in areas such as Diabetes insipidus and Histiocytosis.
His studies in Acute lymphocytic leukemia integrate themes in fields like Childhood Acute Lymphoblastic Leukemia and Incidence.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
